Welcome to our dedicated page for Aberdeen Multi-Market Income Fund news (Ticker: MMT), a resource for investors and traders seeking the latest updates and insights on Aberdeen Multi-Market Income Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aberdeen Multi-Market Income Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aberdeen Multi-Market Income Fund's position in the market.
Aberdeen Multi-Market Income Fund (NYSE:MMT) completed the reorganization of MFS Intermediate High Income Fund (CIF) and MFS Charter Income Trust (MCR) into MMT on June 22, 2026. CIF holders received 0.36109198 and MCR holders 1.33352869 MMT shares per share, based on June 18, 2026 NAVs.
abrdn Inc. became investment adviser and the fund was renamed from MFS Multimarket Income Trust to Aberdeen Multi-Market Income Fund, while keeping ticker MMT and CUSIP 552737108. The investment objective is unchanged, and the portfolio is expected to transition to average investment-grade credit quality over six months.
Aberdeen Multi-Market Income Fund (NYSE:MMT), formerly MFS Multimarket Income Trust, completed the reorganization of MFS Intermediate High Income Fund (CIF) and MFS Charter Income Trust (MCR) on June 22, 2026. CIF and MCR shareholders received MMT shares at NAV-based exchange ratios; Aberdeen became investment adviser and a new trustee board took office. The fund keeps its ticker, CUSIP, and primary objective while transitioning to an average investment grade portfolio over about six months.
Summary not available.
Summary not available.